Total hip replacement with the Charnley prosthesis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000601:surgery; D001178:Arthroplasty; D002512:Cephalothin / Q000627:therapeutic use; D004414:Dyspareunia / Q000209:etiology; D005260:Female; D005264:Femoral Fractures / Q000209:etiology; D005500:Follow-Up Studies; D006615:Hip / Q000601:surgery*; D006617:Hip Dislocation / Q000209:etiology; D006621:Hip Joint; D006801:Humans; D007239:Infections / Q000209:etiology; D007595:Joint Prosthesis / Q000009:adverse effects; D008297:Male; D008722:Methods; D008875:Middle Aged; D010003:Osteoarthritis / Q000601:surgery; D011182:Postoperative Care; D011183:Postoperative Complications; D011474:Prosthesis Design; D013924:Thrombophlebitis / Q000209:etiology
D000900:Anti-Bacterial Agents; D002512:Cephalothin